Funder: Pfizer Inc.
Due Dates: April 14, 2026 (Submission Deadline, full application, 23:59 EST)
Funding Amounts: Up to $100,000 per project; maximum project length 6 months; total available budget $100,000.
Summary: Supports interdisciplinary education to improve healthcare professionals’ knowledge and practice of baseline assessments before starting S1P receptor modulator therapy in adults with ulcerative colitis.